Synthesis of glycomimetics and gycodendrimers of biological interests

抗生素对细菌感染的耐药性是卫生保健系统的一个主要问题。因此，需要新的和替代的战略来防治疾病，其中，预防方法，如接种疫苗已经非常成功。在发达国家，由于大规模的疫苗接种计划，肺炎、肺结核和脑膜炎等重要传染病已经被根除。在这方面，我们集团以前为两种此类疫苗的商业化作出了贡献。我们在此提出了两种新颖而有前途的方法，旨在通过以下两种方法预防感染的早期阶段：a)利用菌柱尖端的碳水化合物结合蛋白来阻止细菌附着和定植宿主组织；b)使用称为菌柱杀剂的新疗法来阻止这些菌柱的组装。因此，产生耐药性的可能性大大降低，因为细菌无法在不阻碍其附着过程的情况下改变其碳水化合物受体。

Antibiotic resistance to bacterial infections is a major concern to health care systems. Hence new and alternative strategies to fight diseases are required and amongst these, prophylactic methods such as vaccinations have been extremely successful. Important infectious diseases like pneumonia, tuberculosis, and meningitis have been eradicated in developed countries due to massive vaccination programs. In this regard, our group has previously contributed to the commercialization of two such vaccines. We are proposing herein two novel and promising approaches aimed at preventing the early stage of infections by a) blocking bacteria from attaching and colonizing host tissues by virtue of their carbohydrate binding proteins present at the tip of their pilli and b) by stopping the assembly of these pilli using new therapies called pilicides. The likelihood of developing resistance is therefore greatly reduced since bacteria cannot mutate their carbohydrate receptors without impeding their attachment processes.